Logo image of HCAI

HUACHEN AI PARKING MANAGEM-A (HCAI) Stock Fundamental Analysis

NASDAQ:HCAI - KYG4645R1149 - Common Stock

0.7002 USD
+0.09 (+14.15%)
Last: 9/2/2025, 8:08:12 PM
0.6921 USD
-0.01 (-1.16%)
After Hours: 9/2/2025, 8:08:12 PM
Fundamental Rating

5

Taking everything into account, HCAI scores 5 out of 10 in our fundamental rating. HCAI was compared to 128 industry peers in the Machinery industry. HCAI has an excellent financial health rating, but there are some minor concerns on its profitability. HCAI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year HCAI was profitable.
In the past year HCAI had a positive cash flow from operations.
HCAI Yearly Net Income VS EBIT VS OCF VS FCFHCAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

HCAI has a Return On Assets of 8.05%. This is in the better half of the industry: HCAI outperforms 73.44% of its industry peers.
HCAI's Return On Equity of 23.34% is amongst the best of the industry. HCAI outperforms 88.28% of its industry peers.
With an excellent Return On Invested Capital value of 13.71%, HCAI belongs to the best of the industry, outperforming 81.25% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HCAI is in line with the industry average of 9.99%.
The 3 year average ROIC (10.36%) for HCAI is below the current ROIC(13.71%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.05%
ROE 23.34%
ROIC 13.71%
ROA(3y)5.15%
ROA(5y)N/A
ROE(3y)16.83%
ROE(5y)N/A
ROIC(3y)10.36%
ROIC(5y)N/A
HCAI Yearly ROA, ROE, ROICHCAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20

1.3 Margins

HCAI's Profit Margin of 5.21% is in line compared to the rest of the industry. HCAI outperforms 49.22% of its industry peers.
HCAI has a Operating Margin (6.88%) which is in line with its industry peers.
With a Gross Margin value of 13.46%, HCAI is not doing good in the industry: 84.38% of the companies in the same industry are doing better.
HCAI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.88%
PM (TTM) 5.21%
GM 13.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.75%
GM growth 5YN/A
HCAI Yearly Profit, Operating, Gross MarginsHCAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30 40

More info and screens

7

2. Health

2.1 Basic Checks

HCAI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for HCAI has been reduced compared to 1 year ago.
HCAI has a better debt/assets ratio than last year.
HCAI Yearly Shares OutstandingHCAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
HCAI Yearly Total Debt VS Total AssetsHCAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

HCAI has an Altman-Z score of 3.45. This indicates that HCAI is financially healthy and has little risk of bankruptcy at the moment.
HCAI's Altman-Z score of 3.45 is fine compared to the rest of the industry. HCAI outperforms 61.72% of its industry peers.
HCAI has a debt to FCF ratio of 7.68. This is a slightly negative value and a sign of low solvency as HCAI would need 7.68 years to pay back of all of its debts.
HCAI has a Debt to FCF ratio of 7.68. This is comparable to the rest of the industry: HCAI outperforms 42.19% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that HCAI is not too dependend on debt financing.
HCAI has a better Debt to Equity ratio (0.18) than 73.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Altman-Z 3.45
ROIC/WACC1.47
WACC9.33%
HCAI Yearly LT Debt VS Equity VS FCFHCAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 2.58 indicates that HCAI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.58, HCAI is in the better half of the industry, outperforming 67.19% of the companies in the same industry.
HCAI has a Quick Ratio of 2.47. This indicates that HCAI is financially healthy and has no problem in meeting its short term obligations.
HCAI has a Quick ratio of 2.47. This is amongst the best in the industry. HCAI outperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.47
HCAI Yearly Current Assets VS Current LiabilitesHCAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

HCAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.87%, which is quite impressive.
Looking at the last year, HCAI shows a very strong growth in Revenue. The Revenue has grown by 58.19%.
The Revenue has been growing by 69.18% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.67%
Revenue 1Y (TTM)58.19%
Revenue growth 3Y69.18%
Revenue growth 5YN/A
Sales Q2Q%19.45%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCAI Yearly Revenue VS EstimatesHCAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

HCAI is valuated cheaply with a Price/Earnings ratio of 5.84.
Based on the Price/Earnings ratio, HCAI is valued cheaply inside the industry as 98.44% of the companies are valued more expensively.
HCAI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.90.
Industry RankSector Rank
PE 5.84
Fwd PE N/A
HCAI Price Earnings VS Forward Price EarningsHCAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HCAI is valued cheaper than 96.88% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HCAI indicates a rather cheap valuation: HCAI is cheaper than 80.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.7
EV/EBITDA 6.17
HCAI Per share dataHCAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HCAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HUACHEN AI PARKING MANAGEM-A

NASDAQ:HCAI (9/2/2025, 8:08:12 PM)

After market: 0.6921 -0.01 (-1.16%)

0.7002

+0.09 (+14.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-15 2025-05-15
Earnings (Next)N/A N/A
Inst Owners0.03%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.62M
AnalystsN/A
Price TargetN/A
Short Float %2.78%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.84
Fwd PE N/A
P/S 0.33
P/FCF 15.7
P/OCF 15.68
P/B 1.49
P/tB 1.49
EV/EBITDA 6.17
EPS(TTM)0.12
EY17.14%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.04
FCFY6.37%
OCF(TTM)0.04
OCFY6.38%
SpS2.1
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.05%
ROE 23.34%
ROCE 15.04%
ROIC 13.71%
ROICexc 13.73%
ROICexgc 13.73%
OM 6.88%
PM (TTM) 5.21%
GM 13.46%
FCFM 2.12%
ROA(3y)5.15%
ROA(5y)N/A
ROE(3y)16.83%
ROE(5y)N/A
ROIC(3y)10.36%
ROIC(5y)N/A
ROICexc(3y)10.5%
ROICexc(5y)N/A
ROICexgc(3y)10.51%
ROICexgc(5y)N/A
ROCE(3y)11.67%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.75%
GM growth 5YN/A
F-Score6
Asset Turnover1.55
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Debt/EBITDA 0.51
Cap/Depr 0.27%
Cap/Sales 0%
Interest Coverage 7.99
Cash Conversion 26.45%
Profit Quality 40.75%
Current Ratio 2.58
Quick Ratio 2.47
Altman-Z 3.45
F-Score6
WACC9.33%
ROIC/WACC1.47
Cap/Depr(3y)68.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)58.19%
Revenue growth 3Y69.18%
Revenue growth 5YN/A
Sales Q2Q%19.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y144.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y161.09%
OCF growth 3Y-18.85%
OCF growth 5YN/A